Lloyds Banking Group plc (LON:LLOY) today announced that it has completed the acquisition of MBNA Ltd (MBNA), a UK consumer credit card business, from FIA Jersey Holdings Limited, a wholly..
Silence Therapeutics plc (LON:SLN) a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announced today the hiring..
Hardide plc (LON:HDD) CEO Phil Kirkham talks to DirectorsTalk about their new contract with General Electric Company Inc. Phil talks us through the deal and what its worth to the..
Evgen Pharma Plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced an update on its two Phase II clinical..
ImmuPharma PLC (LON:IMM), the specialist drug discovery and development company, has today provided its final results for the twelve months ended 31 December 2016 (the “Period”). Key Highlights (including post..
Goldplat plc, (LON:GDP) the AIM listed gold producer, has today announced the Board appointments of Sango Ntsaluba as Non-Executive Director and Werner Klingenberg as Finance Director, both with immediate effect...
ValiRx Plc (LON:VAL) is a clinical-stage bio-pharmaceutical company focused on the development of therapeutics for the treatment of cancer, associated biomarkers and companion diagnostics. The company’s two leading assets are..
